High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements

general

High-grade B-cell lymphoma characterized by the abnormal rearrangement of two genes, MYC gene and either BCL2 or BCL6 genes. Patients with this type of lymphoma usually respond poorly to standard treatments and have a poor prognosis.

57

Centers

109

Active Trials

$1.8B

Cancer Funding

Specific Cancer Types(3)

Top Centers for High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements(57)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
Active Research Program
53.1
2
NCI Comprehensive
Active Research Program
53.1
3
NCI Comprehensive
Active Research Program
53.1
4
NCI Comprehensive
Active Research Program
53.1
5
NCI Comprehensive
Active Research Program
53.1
6
NCI Comprehensive
Active Research Program
53.1
7
NCI Comprehensive
Active Research Program
53.1
8
NCI Comprehensive
Active Research Program
53.1
9
NCI Comprehensive
Active Research Program
53.1
10
NCI Comprehensive
Active Research Program
53.1
1153.1
12
NCI Comprehensive
Active Research Program
53.1
13
NCI Comprehensive
Active Research Program
53.1
14
NCI Comprehensive
Active Research Program
53.1
15
NCI Comprehensive
Active Research Program
53.1
16
NCI Comprehensive
Active Research Program
53.1
17
NCI Comprehensive
Active Research Program
53.1
18
NCI Comprehensive
Active Research Program
53.1
19
NCI Clinical
Active Research Program
53.1
20
NCI Comprehensive
Active Research Program
53.1
21
Active Research Program
53.1
22
NCI Comprehensive
Active Research Program
53.1
23
Active Research Program
53.1
24
NCI Comprehensive
Active Research Program
53.1
25
NCI Comprehensive
Active Research Program
53.1
26
NCI Clinical
Active Research Program
53.1
27
NCI Comprehensive
Active Research Program
53.1
28
NCI Comprehensive
Active Research Program
53.1
29
NCI Comprehensive
Active Research Program
53.1
30
Rutgers Cancer InstituteNew Brunswick, NJ
NCI Comprehensive
Active Research Program
53.1
31
Active Research Program
53.1
32
NCI Clinical
Active Research Program
53.1
33
NCI Comprehensive
Active Research Program
53.1
34
Active Research Program
53.1
35
Active Research Program
53.1
36
Active Research Program
53.1
37
NCI Basic_laboratory
Active Research Program
53.1
38
Active Research Program
53.1
39
Active Research Program
53.1
40
Active Research Program
53.1
41
Active Research Program
53.1
42
Active Research Program
53.1
43
Active Research Program
53.1
44
Active Research Program
53.1
45
Active Research Program
53.1
46
Active Research Program
53.1
47
Active Research Program
53.1
48
NCI Comprehensive
30.6
49
NCI Comprehensive
30.6
50
NCI Comprehensive
30.6
5130.6
52
Cedars-Sinai CancerLos Angeles, CA
30.6
53
NCI Comprehensive
54
NCI Comprehensive
55
Masonic Cancer CenterMinneapolis, MN
NCI Comprehensive
56
NCI Comprehensive
57

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →